Answers are grounded in this paper and cite their sources.
Animal study demonstrates that granulocyte colony-stimulating factor reduces anthrax lethal toxin mortality in mice, indicating erythrocyte mobilization as a therapeutic target.
Anthrax lethal toxin (LT), one of the primary virulence factors of Bacillus anthracis, causes anthrax-like symptoms and death in animals. Experiments have indicated that levels of erythrocytopenia and hypoxic stress are associated with disease severity after administering LT. In this study, the granulocyte colony-stimulating factor (G-CSF) was used as a therapeutic agent to ameliorate anthrax-LT- and spore-induced mortality in C57BL/6J mice. We demonstrated that G-CSF promoted the mobilization of mature erythrocytes to peripheral blood, resulting in a significantly faster recovery from erythrocytopenia. In addition, combined treatment using G-CSF and erythropoietin tended to ameliorate B. anthracis-spore-elicited mortality in mice. Although specific treatments against LT-mediated pathogenesis remain elusive, these results may be useful in developing feasible strategies to treat anthrax.
No takes yet. Share an insight, caveat, or question.
Chang et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: